| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/AAC.48.2.623-625.2004 |
| P8608 | Fatcat ID | release_xylhr43d7nfm3m666axshz46tm |
| P932 | PMC publication ID | 321528 |
| P698 | PubMed publication ID | 14742221 |
| P2093 | author name string | Brian J Wilkinson | |
| Arunachalam Muthaiyan | |||
| Radheshyam K Jayaswal | |||
| P2860 | cites work | A highly vancomycin-resistant laboratory mutant of Staphylococcus aureus | Q71540209 |
| Vancomycin resistance in staphylococci | Q80098627 | ||
| Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus | Q24679159 | ||
| Genome and virulence determinants of high virulence community-acquired MRSA | Q28202214 | ||
| Whole genome sequencing of meticillin-resistant Staphylococcus aureus | Q28202807 | ||
| The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants | Q28492576 | ||
| Mismatch repair in replication fidelity, genetic recombination, and cancer biology | Q29616483 | ||
| Mutation frequencies and antibiotic resistance | Q33945503 | ||
| Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds | Q33978671 | ||
| A spectrum of changes occurs in peptidoglycan composition of glycopeptide-intermediate clinical Staphylococcus aureus isolates | Q33981239 | ||
| Staphylococcus aureus resistant to vancomycin--United States, 2002. | Q34141070 | ||
| An elevated mutation frequency favors development of vancomycin resistance in Staphylococcus aureus | Q34142416 | ||
| High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. | Q34508854 | ||
| Preliminary analysis of the genetic basis for vancomycin resistance in Staphylococcus aureus strain Mu50. | Q34508887 | ||
| Molecular genetics of methicillin-resistant Staphylococcus aureus | Q34796521 | ||
| Mutations in the DNA mismatch repair proteins MutS and MutL of oxazolidinone-resistant or -susceptible Enterococcus faecium | Q36048384 | ||
| Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. | Q39474811 | ||
| Depletion of the cellular amounts of the MutS and MutH methyl-directed mismatch repair proteins in stationary-phase Escherichia coli K-12 cells | Q39841075 | ||
| Spontaneous mutators in bacteria: insights into pathways of mutagenesis and repair | Q46617407 | ||
| High mutation frequencies among Escherichia coli and Salmonella pathogens | Q48057867 | ||
| Insertional inactivation of mutS in Staphylococcus aureus reveals potential for elevated mutation frequencies, although the prevalence of mutators in clinical isolates is low. | Q52861291 | ||
| Inactivated pbp4 in highly glycopeptide-resistant laboratory mutants of Staphylococcus aureus. | Q54090832 | ||
| Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50. | Q54120201 | ||
| Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibility | Q54259069 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Staphylococcus aureus | Q188121 |
| P304 | page(s) | 623-625 | |
| P577 | publication date | 2004-02-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Intact mutS in laboratory-derived and clinical glycopeptide-intermediate Staphylococcus aureus strains | |
| P478 | volume | 48 |
| Q40166227 | Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus |
| Q36072225 | Glycopeptide resistance in gram-positive cocci: a review |
| Q24646677 | Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications |
| Q22065663 | The emergence of antibiotic resistance by mutation |
| Q95355781 | Vancomycin Resistance in Staphylococcus aureus |
Search more.